China Biologic Products Holdings Inc - Company Profile

Powered by

All the sales intelligence you need on China Biologic Products Holdings Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how China Biologic Products Holdings Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with China Biologic Products Holdings Inc.

Back to companies

China Biologic Products Holdings Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

China Biologic Products Holdings Inc, a subsidiary of CBPO Holdings Ltd, is a biopharmaceutical company that focuses on research and development, production, commercialization of plasma-based products. The company is also involved in the sales of medical devices, mainly regenerative medical biomaterial products. The company’s products find application in medical emergencies and for the treatment and prevention of life threating and immune-deficiency related diseases. Few of the products of company include are Human Hepatitis B Immunoglobulin, Human Albumin, Placenta Polypeptide, and Artificial Dura Mater among others. It offers products to hospitals, other healthcare facilities in China and to distributors. China Biologic is headquartered in Beijing, China.

Gain a 360-degree view of China Biologic Products Holdings Inc and make more informed decisions for your business Gain a 360-degree view of China Biologic Products Holdings Inc and make more informed decisions for your business Learn more
Headquarters China

Address No.9-5, Jiangtai West Road, Beijing, 100016


Telephone 86 10 65983111

Industry Pharmaceuticals and Healthcare

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

China Biologic Products Holdings Inc premium industry data and analytics

14+

Clinical Trials

Determine China Biologic Products Holdings Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

12+

Marketed Drugs

Understand China Biologic Products Holdings Inc’s commercialized product portfolio to stay one step ahead of the market.

6

Sales & Consensus Forecasts

Understand the current and future drug revenue for China Biologic Products Holdings Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

6

Pipeline Drugs

Identify which of China Biologic Products Holdings Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on China Biologic Products Holdings Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
-
Human Fibrinogen
Biopharmaceutical
XYZ
XYZ
XYZ
Understand China Biologic Products Holdings Inc portfolio and identify potential areas for collaboration Understand China Biologic Products Holdings Inc portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters China Biologic Products Holdings Inc Shanghai RAAS Blood Products Co Ltd China Resources Boya Bio-pharmaceutical Group Co Ltd China National Biotec Group Sichuan Yuanda Shuyang Pharmaceutical Co Ltd
Headquarters China China China China China
City Beijing Shanghai Fuzhou Beijing Chengdu
State/Province Beijing Shanghai Jiangxi Beijing Sichuan
No. of Employees - 4,045 1,947 - -
Entity Type Private Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Executives
Name Position Board Since Age
David Li Chairman Executive Board - -
Andy Li Chief Financial Officer Senior Management - -
Wu Kun President Senior Management - -
Sun Bing Chairman-Taibang Tianxinfu Senior Management - -
Pang Guangli Interim Chief Executive Officer Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into China Biologic Products Holdings Inc key executives to enhance your sales strategy Gain insight into China Biologic Products Holdings Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?